152 related articles for article (PubMed ID: 31051372)
21. Active raster scanning with carbon ions: reirradiation in patients with recurrent skull base chordomas and chondrosarcomas.
Uhl M; Welzel T; Oelmann J; Habl G; Hauswald H; Jensen A; Ellerbrock M; Debus J; Herfarth K
Strahlenther Onkol; 2014 Jul; 190(7):686-91. PubMed ID: 24663287
[TBL] [Abstract][Full Text] [Related]
22. Carbon ion radiotherapy for chordomas and low-grade chondrosarcomas of the skull base. Results in 67 patients.
Schulz-Ertner D; Nikoghosyan A; Thilmann C; Haberer T; Jäkel O; Karger C; Scholz M; Kraft G; Wannenmacher M; Debus J
Strahlenther Onkol; 2003 Sep; 179(9):598-605. PubMed ID: 14628125
[TBL] [Abstract][Full Text] [Related]
23. Analysis of the relationship between tumor dose inhomogeneity and local control in patients with skull base chordoma.
Terahara A; Niemierko A; Goitein M; Finkelstein D; Hug E; Liebsch N; O'Farrell D; Lyons S; Munzenrider J
Int J Radiat Oncol Biol Phys; 1999 Sep; 45(2):351-8. PubMed ID: 10487555
[TBL] [Abstract][Full Text] [Related]
24. Proton beam therapy for skull base chordomas in 106 patients: A dose adaptive radiation protocol.
Fung V; Calugaru V; Bolle S; Mammar H; Alapetite C; Maingon P; De Marzi L; Froelich S; Habrand JL; Dendale R; Noël G; Feuvret L
Radiother Oncol; 2018 Aug; 128(2):198-202. PubMed ID: 29310903
[TBL] [Abstract][Full Text] [Related]
25. Effectiveness of carbon ion radiotherapy in the treatment of skull-base chordomas.
Schulz-Ertner D; Karger CP; Feuerhake A; Nikoghosyan A; Combs SE; Jäkel O; Edler L; Scholz M; Debus J
Int J Radiat Oncol Biol Phys; 2007 Jun; 68(2):449-57. PubMed ID: 17363188
[TBL] [Abstract][Full Text] [Related]
26. Skull base chordomas: efficacy of surgery followed by carbon ion radiotherapy.
Takahashi S; Kawase T; Yoshida K; Hasegawa A; Mizoe JE
Acta Neurochir (Wien); 2009 Jul; 151(7):759-69. PubMed ID: 19434365
[TBL] [Abstract][Full Text] [Related]
27. A tumour control probability model for radiotherapy of prostate cancer using magnetic resonance imaging-based apparent diffusion coefficient maps.
Casares-Magaz O; van der Heide UA; Rørvik J; Steenbergen P; Muren LP
Radiother Oncol; 2016 Apr; 119(1):111-6. PubMed ID: 26987473
[TBL] [Abstract][Full Text] [Related]
28. Is there a role for conventional MRI and MR diffusion-weighted imaging for distinction of skull base chordoma and chondrosarcoma?
Müller U; Kubik-Huch RA; Ares C; Hug EB; Löw R; Valavanis A; Ahlhelm FJ
Acta Radiol; 2016 Feb; 57(2):225-32. PubMed ID: 25722460
[TBL] [Abstract][Full Text] [Related]
29. Treatment outcomes of proton or carbon ion therapy for skull base chordoma: a retrospective study.
Takagi M; Demizu Y; Nagano F; Terashima K; Fujii O; Jin D; Mima M; Niwa Y; Katsui K; Suga M; Yamashita T; Akagi T; Sakata KI; Fuwa N; Okimoto T
Radiat Oncol; 2018 Nov; 13(1):232. PubMed ID: 30477528
[TBL] [Abstract][Full Text] [Related]
30. Randomised trial of proton vs. carbon ion radiation therapy in patients with chordoma of the skull base, clinical phase III study HIT-1-Study.
Nikoghosyan AV; Karapanagiotou-Schenkel I; Münter MW; Jensen AD; Combs SE; Debus J
BMC Cancer; 2010 Nov; 10():607. PubMed ID: 21054824
[TBL] [Abstract][Full Text] [Related]
31. Effectiveness and safety of spot scanning proton radiation therapy for chordomas and chondrosarcomas of the skull base: first long-term report.
Ares C; Hug EB; Lomax AJ; Bolsi A; Timmermann B; Rutz HP; Schuller JC; Pedroni E; Goitein G
Int J Radiat Oncol Biol Phys; 2009 Nov; 75(4):1111-8. PubMed ID: 19386442
[TBL] [Abstract][Full Text] [Related]
32. On the cost-effectiveness of Carbon ion radiation therapy for skull base chordoma.
Jäkel O; Land B; Combs SE; Schulz-Ertner D; Debus J
Radiother Oncol; 2007 May; 83(2):133-8. PubMed ID: 17490770
[TBL] [Abstract][Full Text] [Related]
33. Radiotherapy for chordomas and low-grade chondrosarcomas of the skull base with carbon ions.
Schulz-Ertner D; Haberer T; Jäkel O; Thilmann C; Krämer M; Enghardt W; Kraft G; Wannenmacher M; Debus J
Int J Radiat Oncol Biol Phys; 2002 May; 53(1):36-42. PubMed ID: 12007939
[TBL] [Abstract][Full Text] [Related]
34. Influence of Residual Tumor Volume and Radiation Dose Coverage in Outcomes for Clival Chordoma.
McDonald MW; Linton OR; Moore MG; Ting JY; Cohen-Gadol AA; Shah MV
Int J Radiat Oncol Biol Phys; 2016 May; 95(1):304-311. PubMed ID: 26519991
[TBL] [Abstract][Full Text] [Related]
35. Results of spot-scanning proton radiation therapy for chordoma and chondrosarcoma of the skull base: the Paul Scherrer Institut experience.
Weber DC; Rutz HP; Pedroni ES; Bolsi A; Timmermann B; Verwey J; Lomax AJ; Goitein G
Int J Radiat Oncol Biol Phys; 2005 Oct; 63(2):401-9. PubMed ID: 16168833
[TBL] [Abstract][Full Text] [Related]
36. Positron emission tomography/computed tomography imaging of residual skull base chordoma before radiotherapy using fluoromisonidazole and fluorodeoxyglucose: potential consequences for dose painting.
Mammar H; Kerrou K; Nataf V; Pontvert D; Clemenceau S; Lot G; George B; Polivka M; Mokhtari K; Ferrand R; Feuvret L; Habrand JL; Pouysségur J; Mazure N; Talbot JN
Int J Radiat Oncol Biol Phys; 2012 Nov; 84(3):681-7. PubMed ID: 22391104
[TBL] [Abstract][Full Text] [Related]
37. Hypofractionated stereotactic radiation therapy for skull base and upper cervical chordoma and chondrosarcoma: preliminary results.
Gwak HS; Yoo HJ; Youn SM; Chang U; Lee DH; Yoo SY; Rhee CH
Stereotact Funct Neurosurg; 2005; 83(5-6):233-43. PubMed ID: 16601376
[TBL] [Abstract][Full Text] [Related]
38. Temporal lobe (TL) damage following surgery and high-dose photon and proton irradiation in 96 patients affected by chordomas and chondrosarcomas of the base of the skull.
Santoni R; Liebsch N; Finkelstein DM; Hug E; Hanssens P; Goitein M; Smith AR; O'Farrell D; Efird JT; Fullerton B; Munzenrider JE
Int J Radiat Oncol Biol Phys; 1998 Apr; 41(1):59-68. PubMed ID: 9588918
[TBL] [Abstract][Full Text] [Related]
39. Proton radiation therapy for chordomas and chondrosarcomas of the skull base.
Hug EB; Slater JD
Neurosurg Clin N Am; 2000 Oct; 11(4):627-38. PubMed ID: 11082173
[TBL] [Abstract][Full Text] [Related]
40. Assessment of potential advantages of relevant ions for particle therapy: a model based study.
Grün R; Friedrich T; Krämer M; Zink K; Durante M; Engenhart-Cabillic R; Scholz M
Med Phys; 2015 Feb; 42(2):1037-47. PubMed ID: 25652516
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
